Antigen-loaded dissolving microneedle array as a novel tool for percutaneous vaccination

Area of Science:

• Biomedical Engineering
• Immunology
• Materials Science

Background:

• The skin is a prime site for vaccination due to its rich distribution of immune cells.
• Conventional vaccine delivery methods can be invasive and require trained personnel.
• Novel delivery systems are needed to improve vaccine efficacy and patient compliance.

Purpose of the Study:

• To investigate antigen-loaded dissolving microneedle array (dMNA) patches as a novel vaccine delivery system.
• To assess the efficiency of dMNA patches in delivering antigens into the skin.
• To evaluate the immunogenicity of vaccines delivered via dMNA patches.

Main Methods:

• Fabrication of micron-scale needles using chondroitin sulfate mixed with ovalbumin (a model antigen).
• Application of dMNA patches to deliver antigens into the skin of mice.
• Measurement of antigen delivery time and induction of antigen-specific antibody responses.
• Comparison of dMNA patch immunization efficiency with conventional intradermal injections.

Main Results:

• dMNA patches effectively delivered substantial amounts of ovalbumin into the skin within 3 minutes.
• Antigen delivery via dMNA patches induced robust antigen-specific antibody responses in mice sera.
• The antibody dose-response relationship indicated that dMNA patch immunization efficiency was comparable to intradermal injections.

Conclusions:

• Antigen-loaded dMNA patches represent a promising new platform for percutaneous vaccination.
• dMNA technology offers an effective and potentially less invasive alternative for vaccine delivery.
• Further development of dMNA patches could enhance vaccine accessibility and immune response.